Omega-3 Fatty Acids and Their Potential Role in Parkinson’s Disease Research
A scientific review explores how omega-3 fatty acids may influence inflammation, oxidative stress, and neuron function pathways implicated in Parkinson's disease models.
A growing library of the omega-3 research we're following — summarized and categorized so you can find what matters to you.
A scientific review explores how omega-3 fatty acids may influence inflammation, oxidative stress, and neuron function pathways implicated in Parkinson's disease models.
This narrative review suggests omega-3 fatty acids may help regulate pathways linked to age-related protein damage (AGEs) and related inflammation, though more direct clinical trials in older adults are needed.
Nursing mothers who took DHA supplements for 150 days had higher breast milk DHA levels, and their infants showed better growth and neurodevelopmental scores than infants of non-supplemented mothers.
Across 16 UK Biobank studies, higher blood levels of omega-3s and DHA were consistently linked to lower risk of heart disease, stroke, fatty liver disease, and type 2 diabetes.
In a mouse model, an omega-3 fatty acid helped restore gut barrier function and reduce ovarian inflammation linked to PCOS-like symptoms.
In a Her-2 breast cancer mouse model, an omega-3 rich diet led to 55% smaller and 42% lighter tumors compared to an omega-6 rich diet, while exercise effects varied by diet type.
Researchers propose that red blood cell membrane fluidity, influenced by omega-3 intake, may serve as a new biomarker for cardiovascular risk beyond standard cholesterol tests.
Patients hospitalized with severe COVID-19 had significantly lower Omega-3 Index levels than those with mild illness.
People with higher blood DHA (omega-3) levels had lower rates of testing positive for and being hospitalized with COVID-19 in a large UK population study.